Private Capital Management, LLC Harrow Health, Inc. Transaction History
Private Capital Management, LLC
- $852 Million
- Q3 2024
A detailed history of Private Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Private Capital Management, LLC holds 2,163,681 shares of HROW stock, worth $73.2 Million. This represents 11.41% of its overall portfolio holdings.
Number of Shares
2,163,681
Previous 2,714,851
20.3%
Holding current value
$73.2 Million
Previous $56.7 Million
71.53%
% of portfolio
11.41%
Previous 7.1%
Shares
10 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$135 Million32.75% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$72.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$63.2 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$24.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA723KShares$24.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $916M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...